172 related articles for article (PubMed ID: 18032572)
21. Distinct roles for the kainate receptor subunits GluR5 and GluR6 in kainate-induced hippocampal gamma oscillations.
Fisahn A; Contractor A; Traub RD; Buhl EH; Heinemann SF; McBain CJ
J Neurosci; 2004 Oct; 24(43):9658-68. PubMed ID: 15509753
[TBL] [Abstract][Full Text] [Related]
22. Binding and selectivity of the marine toxin neodysiherbaine A and its synthetic analogues to GluK1 and GluK2 kainate receptors.
Unno M; Shinohara M; Takayama K; Tanaka H; Teruya K; Doh-ura K; Sakai R; Sasaki M; Ikeda-Saito M
J Mol Biol; 2011 Oct; 413(3):667-83. PubMed ID: 21893069
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes.
Jane DE; Hoo K; Kamboj R; Deverill M; Bleakman D; Mandelzys A
J Med Chem; 1997 Oct; 40(22):3645-50. PubMed ID: 9357531
[TBL] [Abstract][Full Text] [Related]
24. Ligands for ionotropic glutamate receptors.
Swanson GT; Sakai R
Prog Mol Subcell Biol; 2009; 46():123-57. PubMed ID: 19184587
[TBL] [Abstract][Full Text] [Related]
25. The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors.
Donevan SD; Beg A; Gunther JM; Twyman RE
J Pharmacol Exp Ther; 1998 May; 285(2):539-45. PubMed ID: 9580595
[TBL] [Abstract][Full Text] [Related]
26. Presynaptic regulation of the inhibitory transmission by GluR5-containing kainate receptors in spinal substantia gelatinosa.
Xu H; Wu LJ; Zhao MG; Toyoda H; Vadakkan KI; Jia Y; Pinaud R; Zhuo M
Mol Pain; 2006 Sep; 2():29. PubMed ID: 16948848
[TBL] [Abstract][Full Text] [Related]
27. Activation of kainate receptors controls the number of functional glutamatergic synapses in the area CA1 of rat hippocampus.
Vesikansa A; Sallert M; Taira T; Lauri SE
J Physiol; 2007 Aug; 583(Pt 1):145-57. PubMed ID: 17569736
[TBL] [Abstract][Full Text] [Related]
28. Enantioselective Synthesis of (-)-Dysiherbaine.
Do H; Kang CW; Cho JH; Gilbertson SR
Org Lett; 2015 Aug; 17(16):3972-4. PubMed ID: 26258884
[TBL] [Abstract][Full Text] [Related]
29. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro pharmacology at AMPA and kainate preferring glutamate receptors of 4-heteroarylmethylidene glutamate analogues.
Valgeirsson J; Christensen JK; Kristensen AS; Pickering DS; Nielsen B; Fischer CH; Bräuner-Osborne H; Nielsen EØ; Krogsgaard-Larsen P; Madsen U
Bioorg Med Chem; 2003 Oct; 11(20):4341-9. PubMed ID: 13129570
[TBL] [Abstract][Full Text] [Related]
31. [3H]ATPA: a high affinity ligand for GluR5 kainate receptors.
Hoo K; Legutko B; Rizkalla G; Deverill M; Hawes CR; Ellis GJ; Stensbol TB; Krogsgaard-Larsen P; Skolnick P; Bleakman D
Neuropharmacology; 1999 Dec; 38(12):1811-7. PubMed ID: 10608276
[TBL] [Abstract][Full Text] [Related]
32. Assembly and cell surface expression of KA-2 subunit-containing kainate receptors.
Gallyas F; Ball SM; Molnar E
J Neurochem; 2003 Sep; 86(6):1414-27. PubMed ID: 12950450
[TBL] [Abstract][Full Text] [Related]
33. Effect of RNA editing and subunit co-assembly single-channel properties of recombinant kainate receptors.
Swanson GT; Feldmeyer D; Kaneda M; Cull-Candy SG
J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):129-42. PubMed ID: 8730589
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.
Dolman NP; Troop HM; More JC; Alt A; Knauss JL; Nistico R; Jack S; Morley RM; Bortolotto ZA; Roberts PJ; Bleakman D; Collingridge GL; Jane DE
J Med Chem; 2005 Dec; 48(24):7867-81. PubMed ID: 16302825
[TBL] [Abstract][Full Text] [Related]
35. Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine tolerance.
Bogulavsky JJ; Gregus AM; Kim PT; Costa AC; Rajadhyaksha AM; Inturrisi CE
J Pharmacol Exp Ther; 2009 Feb; 328(2):579-87. PubMed ID: 18957577
[TBL] [Abstract][Full Text] [Related]
36. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission.
Clarke VR; Ballyk BA; Hoo KH; Mandelzys A; Pellizzari A; Bath CP; Thomas J; Sharpe EF; Davies CH; Ornstein PL; Schoepp DD; Kamboj RK; Collingridge GL; Lodge D; Bleakman D
Nature; 1997 Oct; 389(6651):599-603. PubMed ID: 9335499
[TBL] [Abstract][Full Text] [Related]
37. Glutamate receptors on myelinated spinal cord axons: II. AMPA and GluR5 receptors.
Ouardouz M; Coderre E; Zamponi GW; Hameed S; Yin X; Trapp BD; Stys PK
Ann Neurol; 2009 Feb; 65(2):160-6. PubMed ID: 19224531
[TBL] [Abstract][Full Text] [Related]
38. LY339434, a GluR5 kainate receptor agonist.
Small B; Thomas J; Kemp M; Hoo K; Ballyk B; Deverill M; Ogden AM; Rubio A; Pedregal C; Bleakman D
Neuropharmacology; 1998; 37(10-11):1261-7. PubMed ID: 9849663
[TBL] [Abstract][Full Text] [Related]
39. Total synthesis and biological evaluation of neodysiherbaine A and analogues.
Shoji M; Akiyama N; Tsubone K; Lash LL; Sanders JM; Swanson GT; Sakai R; Shimamoto K; Oikawa M; Sasaki M
J Org Chem; 2006 Jul; 71(14):5208-20. PubMed ID: 16808508
[TBL] [Abstract][Full Text] [Related]
40. Astrocyte-mediated activation of neuronal kainate receptors.
Liu QS; Xu Q; Arcuino G; Kang J; Nedergaard M
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3172-7. PubMed ID: 14766987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]